Hims & Hers Health, Inc. Class Action Lawsuit Filed by Rosen Law Firm

Strategic Insights -

The Rosen Law Firm has filed a class action lawsuit on behalf of investors who purchased common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025, and June 23, 2025. The lawsuit claims that the company made false and misleading statements about its partnership with Novo Nordisk A/S and its access to the weight-loss drug Wegovy. As a result, investors who suffered damages may be entitled to compensation.

Key Takeaways:

  • The class action lawsuit was filed on behalf of investors who purchased Hims common stock during the period from April 29, 2025, to June 23, 2025.
  • The lawsuit claims that Hims made false and misleading statements about its partnership with Novo Nordisk A/S and its access to the weight-loss drug Wegovy.
  • The suit alleges that Hims failed to disclose that branded Wegovy would be offered alongside compounded semaglutide options on the Hims platform.
  • The Rosen Law Firm is seeking to recover damages for investors who suffered losses due to Hims' allegedly false and misleading statements.
  • The lead plaintiff deadline is August 25, 2025, and investors who wish to serve as lead plaintiff must move the Court by that date.
  • The Rosen Law Firm has a proven track record of success in securities class actions and has recovered hundreds of millions of dollars for investors.

Statistics:

  • The class period for the lawsuit is April 29, 2025, to June 23, 2025.
  • The lead plaintiff deadline is August 25, 2025.
  • The Rosen Law Firm has secured over $438 million for investors in 2019 alone.
  • The firm was ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Sources:

  • Newsfile Corp, "Hims & Hers Health, Inc. Class Action Lawsuit Filed by Rosen Law Firm", July 28, 2025
  • Rosen Law Firm, "Class Action Lawsuit Filed Against Hims & Hers Health, Inc.", July 2025
  • Law360, "Titan of Plaintiffs' Bar: Laurence Rosen of Rosen Law Firm", 2020
  • LinkedIn, Twitter, and Facebook: The Rosen Law Firm ("TRF")